1-7 of 7
intensive care unit
Close
Sort by
Journal Articles

Pretransplantation EASIX predicts intensive care unit admission in allogeneic hematopoietic cell transplantation

Clinical Trials & Observations
Marta Peña, Maria Queralt Salas, Alberto Mussetti, Gabriel Moreno-Gonzalez, Anna Bosch, Beatriz Patiño, Laura Jiménez, Meriem Kara, Rocío Parody, Anna Sureda
Journal: Blood Advances
Blood Adv (2021) 5 (17): 3418–3426.
https://doi.org/10.1182/bloodadvances.2021004812
Published: 2021
Includes: Supplemental data
Journal Articles

Cytokine release syndrome and neurological event costs in lisocabtagene maraleucel–treated patients in the TRANSCEND NHL 001 trial

Jeremy S. Abramson, Tanya Siddiqi, Jacob Garcia, Christine Dehner, Yeonhee Kim, Andy Nguyen, Sophie Snyder, November McGarvey, Matthew Gitlin, Corey Pelletier, Monika P. Jun
Journal: Blood Advances
Blood Adv (2021) 5 (6): 1695–1705.
https://doi.org/10.1182/bloodadvances.2020003531
Published: 2021
Journal Articles

A neutrophil activation signature predicts critical illness and mortality in COVID-19

Clinical Trials & Observations
Matthew L. Meizlish, Alexander B. Pine, Jason D. Bishai, George Goshua, Emily R. Nadelmann, Michael Simonov, C-Hong Chang, Hanming Zhang, Marcus Shallow, Parveen Bahel, Kent Owusu, Yu Yamamoto, Tanima Arora, Deepak S. Atri, Amisha Patel, Rana Gbyli, Jennifer Kwan, Christine H. Won, Charles Dela Cruz, Christina Price, Jonathan Koff, Brett A. King, Henry M. Rinder, F. Perry Wilson, John Hwa, Stephanie Halene, William Damsky, David van Dijk, Alfred I. Lee, Hyung J. Chun
Journal: Blood Advances
Blood Adv (2021) 5 (5): 1164–1177.
https://doi.org/10.1182/bloodadvances.2020003568
Published: 2021
Includes: Supplemental data
Journal Articles

End-of-life care quality outcomes among Medicare beneficiaries with hematologic malignancies

Clinical Trials & Observations
Pamela C. Egan, Thomas W. LeBlanc, Adam J. Olszewski
Journal: Blood Advances
Blood Adv (2020) 4 (15): 3606–3614.
https://doi.org/10.1182/bloodadvances.2020001767
Published: 2020
Includes: Supplemental data
Journal Articles

Patterns of care and clinical outcomes with cytarabine-anthracycline induction chemotherapy for AML patients in the United States

Amer M. Zeidan, Nikolai A. Podoltsev, Xiaoyi Wang, Chi Zhang, Jan Philipp Bewersdorf, Rory M. Shallis, Scott F. Huntington, Natalia Neparidze, Smith Giri, Steven D. Gore, Amy J. Davidoff, Xiaomei Ma, Rong Wang
Journal: Blood Advances
Blood Adv (2020) 4 (8): 1615–1623.
https://doi.org/10.1182/bloodadvances.2020001728
Published: 2020
Journal Articles

Prospective comparison of the HEP score and 4Ts score for the diagnosis of heparin-induced thrombocytopenia

Clinical Trials & Observations
Allyson M. Pishko, Sara Fardin, Daniel S. Lefler, Koosha Paydary, Rolando Vega, Gowthami M. Arepally, Mark Crowther, Lawrence Rice, Douglas B. Cines, Adam Cuker
Journal: Blood Advances
Blood Adv (2018) 2 (22): 3155–3162.
https://doi.org/10.1182/bloodadvances.2018023077
Published: 2018
Includes: Supplemental data
Journal Articles

Soluble GPVI is elevated in injured patients: shedding is mediated by fibrin activation of GPVI

Samantha J. Montague, Céline Delierneux, Christelle Lecut, Nathalie Layios, Robert J. Dinsdale, Christine S.-M. Lee, Natalie S. Poulter, Robert K. Andrews, Peter Hampson, Christopher M. Wearn, Nathalie Maes, Jonathan Bishop, Amy Bamford, Chris Gardiner, Woei Ming Lee, Tariq Iqbal, Naiem Moiemen, Steve P. Watson, Cécile Oury, Paul Harrison, Elizabeth E. Gardiner
Journal: Blood Advances
Blood Adv (2018) 2 (3): 240–251.
https://doi.org/10.1182/bloodadvances.2017011171
Published: 2018
Includes: Supplemental data